Efficacy of the Cardiac Rehabilitation Program in Patients with End-Stage Heart Failure, Heart Transplant Patients, and Left Ventricular Assist Device Recipients

被引:61
|
作者
Karapolat, H. [1 ]
Engin, C. [2 ]
Eroglu, M. [1 ]
Yagdi, T. [2 ]
Zoghi, M. [2 ]
Nalbantgil, S. [2 ]
Durmaz, B. [1 ]
Kirazli, Y. [1 ]
Ozbaran, M. [2 ]
机构
[1] Ege Univ, Phys Med & Rehabil Dept, TR-35100 Izmir, Turkey
[2] Ege Univ, Dept Cardiac Surg, TR-35100 Izmir, Turkey
关键词
QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; TIME-COURSE; METAANALYSIS; TRIAL;
D O I
10.1016/j.transproceed.2013.06.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. The objective of this study was to assess the effects of cardiac rehabilitation on the functional capacity, pulmonary functions, quality of life, and psychological state of patients who had heart failure (HF), heart transplantation (HTx), or a left ventricular assist device (LVAD). Methods. An 8-week exercise program was undertaken by 46 patients diagnosed with end-stage heart failure, 40 of whom had a heart transplantation and 11 were implanted with an LVAD. The patients' functionality was assessed with a maximal oxygen consumption test (pVO(2)), their psychological state with the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI), their quality of life (QOL) with the Short Form 36 (SF 36), and their pulmonary condition with pulmonary function tests (PFTs). Results. A significant improvement was observed in all forced vital capacity (%), forced expiratory volume in 1 second (%), pVO(2), BDI, and most of the subscores of the SF 36 scores at the end of the exercise, compared with the pre-exercise period (P <.05). The intergroup evaluations showed no significant differences among the 3 groups in terms of all assessed changes (F>.05). Conclusion. An 8-week supervised exercise program was observed to improve functional capacity, PFT, QOL, and depression among patients who had HF, HTx, or LVAD. Supervised exercise should be recommended for every patient included in a heart transplant program.
引用
收藏
页码:3381 / 3385
页数:5
相关论文
共 50 条
  • [31] Impact of gender in patients with continuous-flow left ventricular assist device therapy in end-stage heart failure
    Zubarevich, Alina
    Szczechowicz, Marcin
    Osswald, Anja
    Arjomandi Rad, Arian
    Vardanyan, Robert
    Pompeu B O Sa, Michel
    Van den Eynde, Jef
    Schmack, Bastian
    Wendt, Daniel
    Koch, Achim
    Pizanis, Nikolaus
    Kamler, Markus
    Ruhparwar, Arjang
    Weymann, Alexander
    Zhigalov, Konstantin
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2021, 44 (12): : 990 - 997
  • [32] The Use of Left Ventricular Assist Devices in End-Stage Heart Failure
    Blair, Ashley
    CRITICAL CARE NURSING QUARTERLY, 2018, 41 (04) : 376 - 382
  • [33] Heart Transplantation and Left Ventricular Assist Device Therapy: Two Comparable Options in End-Stage Heart Failure?
    Garbade, Jens
    Barten, Markus J.
    Bittner, Hartmuth B.
    Mohr, Friedrich-Wilhelm
    CLINICAL CARDIOLOGY, 2013, 36 (07) : 378 - 382
  • [34] LEFT VENTRICULAR ASSIST DEVICE DOES NOT IMPROVE CELLULAR IMMUNITY IN END-STAGE HEART FAILURE
    Lundgren, Scott
    Lyden, Elizabeth
    Burdorf, Adam
    Hyden, Marshall
    Stoller, Douglas
    Zolty, Ronald
    Um, John
    Lowes, Brian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 950 - 950
  • [35] Long-term use of a left ventricular assist device for end-stage heart failure
    Rose, EA
    Gelijns, AC
    Moskowitz, AJ
    Heitjan, DF
    Stevenson, LW
    Dembitsky, W
    Long, JW
    Ascheim, DD
    Tierney, AR
    Levitan, RG
    Watson, JT
    Meier, P
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20): : 1435 - 1443
  • [36] Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation:: Results of the experience with left ventricular assist device with exercise trial
    Jaski, BE
    Lingle, RJ
    Kim, J
    Branch, KR
    Goldsmith, R
    Johnson, MR
    Lahpor, JR
    Icenogle, TB
    Piña, I
    Adamson, R
    Favrot, LK
    Dembitsky, WP
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (11): : 1031 - 1040
  • [37] Does unloading the heart by a left ventricular assist device (LVAD) in patients with end-stage heart failure result in improvement of cardiomyocyte microscopic structure?
    de Jonge, N
    van Oosterhout, MFM
    van Wichen, DF
    Laphor, JR
    Schipper, MEI
    Gmelig-Meyling, FHJ
    de Weger, RA
    JOURNAL OF PATHOLOGY, 2001, 193 : 38A - 38A
  • [38] LEFT-VENTRICULAR FUNCTION BEFORE AND AFTER INSERTION OF A PULSATILE ASSIST DEVICE IN PATIENTS WITH END-STAGE HEART-FAILURE
    ATHANASOULIS, T
    SEKELA, ME
    NOON, GP
    MAHMARIAN, JJ
    YOUNG, JB
    VERANI, MS
    CIRCULATION, 1990, 82 (04) : 383 - 383
  • [39] Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device
    Ferrari, M
    Kadipasaoglu, KA
    Croitoru, M
    Conger, J
    Myers, T
    Gregoric, I
    Radovancevic, B
    Letsou, GV
    Frazier, OH
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : 226 - 228
  • [40] Open Chest Epicardial Voltage Mapping during Left Ventricular Assist Device Implant in Patients with End-Stage Heart Failure
    Moss, J. D.
    Raiman, M. J.
    Flatley, E. E.
    Ota, T.
    Jeevanandam, V.
    Uriel, N.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S39 - S39